Recovery ⏱ Half-life: Short. Preclinical

Cardiogen

Cardiogen (AED Peptide)

Updated March 15, 2026

Evidence at a Glance

Regulatory statusPreclinical
Khavinson short-peptide bioregulator (Ala-Glu-Asp-Arg); Russian-origin data only, not FDA-approved.
Human evidenceNone
Animal evidenceLimited

Cardiogen is a Russian-developed cardiac tetrapeptide bioregulator backed by Khavinson-group preclinical work, with no controlled human clinical trials.

What the research does not support

  • It is not FDA-approved and is not a treatment for heart disease, heart failure, or myocardial injury.
  • No randomized human trials confirm any cardiovascular benefit; the evidence is preclinical and single-source.
  • Proposed peptide-DNA gene-regulation mechanisms are hypotheses from Russian research, not independently validated in humans.
Half-Life
Short.
Mol. Weight
~320 g/mol

What is Cardiogen?

Cardiogen is a synthetic peptide bioregulator designed to support cardiac tissue function and repair signaling.

Research Applications

Cardiac tissue support, anti-fibrotic research, post-ischemic remodeling, and cardiovascular aging.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard reconstitution or oral.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK, et al. “Short peptides as regulators of gene activity.” Bull Exp Biol Med. 2005

How Cardiogen Works

Cardiogen targets cardiomyocyte gene expression, supporting cellular resilience and anti-fibrotic pathways in cardiac tissue.

Research Findings

Studied in age-related cardiac decline and post-ischemic remodeling models.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Ala-Glu-Asp
Molecular Weight ~320 g/mol
Half-Life Short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK, et al. "Short peptides as regulators of gene activity." Bull Exp Biol Med. 2005

Related Peptides

View all →
BPC-157
Recovery
Gastric pentadecapeptide researched for tissue repair, gut healing, and accelerated recovery across multiple tissue types.
View Profile → Buy Now
KPV
Recovery
Tripeptide fragment of alpha-MSH researched for potent anti-inflammatory activity and gut mucosal healing.
View Profile → Buy Now
Livagen
Recovery
Tetrapeptide bioregulator researched for hepatocyte protection and liver tissue recovery signaling.
View Profile →